Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report)’s stock price gapped down before the market opened on Friday . The stock had previously closed at $23.1750, but opened at $20.49. Hikma Pharmaceuticals shares last traded at $20.49, with a volume of 100 shares changing hands.
Hikma Pharmaceuticals Stock Performance
The company has a quick ratio of 0.72, a current ratio of 1.24 and a debt-to-equity ratio of 0.33. The company’s 50 day moving average price is $23.29 and its 200-day moving average price is $25.58.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Featured Articles
- Five stocks we like better than Hikma Pharmaceuticals
- How to find penny stocks to invest and trade
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- What Are Dividends? Buy the Best Dividend Stocks
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- What to Know About Investing in Penny Stocks
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
